| scholarly article | Q13442814 |
| P50 | author | Robert J. Lederman | Q42549336 |
| Cynthia E. Dunbar | Q52883652 | ||
| R B Thompson | Q73340391 | ||
| P2093 | author name string | Elliot R McVeigh | |
| Venkatesh K Raman | |||
| Alexander J Dick | |||
| Michael A Guttman | |||
| Bradley J Martin | |||
| Zu-Xi Yu | |||
| Jonathan M Hill | |||
| Timothy R Varney | |||
| Breno S S Pessanha | |||
| K Allison Hinds | |||
| P2860 | cites work | Multilineage potential of adult human mesenchymal stem cells | Q27860737 |
| T(1) quantification with inversion recovery TrueFISP. | Q30644157 | ||
| Relaxation effects of clustered particles | Q30685691 | ||
| Retroviral marking and transplantation of rhesus hematopoietic cells by nonmyeloablative conditioning. | Q33329739 | ||
| Cardiomyocytes can be generated from marrow stromal cells in vitro | Q33843659 | ||
| Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. | Q33896810 | ||
| Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography | Q34016136 | ||
| Catheter-based endomyocardial injection with real-time magnetic resonance imaging | Q34119211 | ||
| Genetic marking as an approach to studying in vivo hematopoiesis: progress in the non-human primate model | Q34658509 | ||
| Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination | Q36785284 | ||
| Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells | Q40765346 | ||
| Cell transplantation as future therapy for cardiovascular disease?: A workshop of the National Heart, Lung, and Blood Institute | Q45867419 | ||
| Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep | Q45872229 | ||
| Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. | Q48987592 | ||
| Evaluation of the acute and chronic safety of the biosense injection catheter system in porcine hearts. | Q50515836 | ||
| Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart | Q64379356 | ||
| Ultrasmall superparamagnetic iron oxide-enhanced MR imaging of atherosclerotic plaque in hyperlipidemic rabbits | Q74133728 | ||
| Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects | Q74341231 | ||
| Application of the static dephasing regime theory to superparamagnetic iron-oxide loaded cells | Q74447798 | ||
| The coronary delivery of marrow stromal cells for myocardial regeneration: pathophysiologic and therapeutic implications | Q74583124 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mesenchymal stem cell | Q1922379 |
| cardiac magnetic resonance imaging | Q5038325 | ||
| stem cell MRI | Q108617598 | ||
| P304 | page(s) | 1009-1014 | |
| P577 | publication date | 2003-08-11 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells | |
| P478 | volume | 108 |
| Q42823514 | A molecular MRI probe to detect treatment of cardiac apoptosis in vivo |
| Q30461932 | A shift from cell cultures to creatures: in vivo imaging of small animals in experimental regenerative medicine. |
| Q46387886 | An in vivo multimodal imaging study using MRI and PET of stem cell transplantation after myocardial infarction in rats. |
| Q57187017 | Antibody-mediated cell labeling of peripheral T cells with micron-sized iron oxide particles (MPIOs) allows single cell detection by MRI |
| Q42193815 | Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma |
| Q45252912 | Assessment of safety, accuracy, and human CD34+ cell retention after intramyocardial injections with a helical needle catheter in a porcine model |
| Q58910407 | Biocompatibility and Toxicity of Magnetic Nanoparticles in Regenerative Medicine |
| Q36844563 | Bone marrow-derived stromal cells home to and remain in the infarcted rat heart but fail to improve function: an in vivo cine-MRI study. |
| Q37790602 | CMR for characterization of the myocardium in acute coronary syndromes |
| Q39881335 | Calcium and cyclic nucleotides affect TNF-alpha-induced stem cell migration |
| Q48157837 | Cardiac Chemical Exchange Saturation Transfer MR Imaging Tracking of Cell Survival or Rejection in Mouse Models of Cell Therapy |
| Q26786658 | Cardiac MR imaging: current status and future direction |
| Q36579504 | Cardiac repair--fact or fancy? |
| Q36760556 | Cardiovascular MRI for stem cell therapy |
| Q37530107 | Cardiovascular molecular imaging: an overview |
| Q36406473 | Catheter-based delivery of cells to the heart |
| Q37441802 | Cell labeling and tracking for experimental models using magnetic resonance imaging |
| Q36964549 | Cell therapy in myocardial infarction: emphasis on the role of MRI. |
| Q37187645 | Cell tracking and therapy evaluation of bone marrow monocytes and stromal cells using SPECT and CMR in a canine model of myocardial infarction |
| Q36277263 | Cell-based therapies and imaging in cardiology |
| Q36669952 | Cellular cardiomyoplasty by catheter-based infusion of stem cells in clinical settings |
| Q36546298 | Cellular magnetic resonance imaging: current status and future prospects |
| Q37209833 | Cellular magnetic resonance imaging: potential for use in assessing aspects of cardiovascular disease |
| Q37697688 | Chitosan hydrogel improves mesenchymal stem cell transplant survival and cardiac function following myocardial infarction in rats |
| Q35106957 | Clinically viable magnetic poly(lactide-co-glycolide) particles for MRI-based cell tracking. |
| Q34673571 | Combination of IGF‑1 gene manipulation and 5‑AZA treatment promotes differentiation of mesenchymal stem cells into cardiomyocyte‑like cells |
| Q40171747 | Comparison of imaging techniques for tracking cardiac stem cell therapy |
| Q37772453 | Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy? |
| Q36406455 | Contemplating the bright future of stem cell therapy for cardiovascular disease |
| Q37871924 | Contrast-enhancement cardiac magnetic resonance imaging beyond the scope of viability |
| Q37337649 | Delivering stem cells to the heart in a collagen matrix reduces relocation of cells to other organs as assessed by nanoparticle technology |
| Q34248666 | Delivery and tracking of therapeutic cell preparations for clinical cardiovascular applications. |
| Q33781597 | Design and characterization of a polymeric MRI contrast agent based on PVA for in vivo living-cell tracking. |
| Q35609635 | Determining the fate of seeded cells in venous tissue-engineered vascular grafts using serial MRI |
| Q50670883 | Development of morphology and function of neonatal mouse ventricular myocytes cultured on a hyaluronan-based polymer scaffold. |
| Q33514630 | Dual-modal nanoprobes for imaging of mesenchymal stem cell transplant by MRI and fluorescence imaging |
| Q37253137 | Dynamic Tracking of Injected Mesenchymal Stem Cells after Myocardial Infarction in Rats: A Serial 7T MRI Study. |
| Q30477220 | Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction |
| Q34260802 | Early stem cell engraftment predicts late cardiac functional recovery: preclinical insights from molecular imaging |
| Q34657611 | Ectopic expression of the sodium-iodide symporter enables imaging of transplanted cardiac stem cells in vivo by single-photon emission computed tomography or positron emission tomography |
| Q46173522 | Effectiveness of micron-sized superparamagnetic iron oxide particles as markers for detection of migration of bone marrow-derived mesenchymal stromal cells in a stroke model |
| Q52590928 | Effects of different doses of granulocyte colony-stimulating factor mobilization therapy on ischemic cardiomyopathy. |
| Q34331534 | Effects of iron oxide nanoparticle labeling on human endothelial cells |
| Q34668028 | Embryonic cardiomyocyte, but not autologous stem cell transplantation, restricts infarct expansion, enhances ventricular function, and improves long-term survival |
| Q30487552 | Embryonic stem cell grafting in normal and infarcted myocardium: serial assessment with MR imaging and PET dual detection |
| Q35944159 | Emerging roles for integrated imaging modalities in cardiovascular cell-based therapeutics: a clinical perspective |
| Q33650172 | Engineering complex tissues |
| Q58120574 | Engineering molecular imaging strategies for regenerative medicine |
| Q37578064 | Engraftment of human mesenchymal stem cells in a rat photothrombotic cerebral infarction model : comparison of intra-arterial and intravenous infusion using MRI and histological analysis |
| Q41856860 | Enhanced magnetic cell labeling efficiency using -NH2 coated MPIOs |
| Q50282696 | Ferritin as a reporter gene for in vivo tracking of stem cells by 1.5-T cardiac MRI in a rat model of myocardial infarction |
| Q33831410 | Ferromagnetic resonance for the quantification of superparamagnetic iron oxide nanoparticles in biological materials |
| Q34293041 | Gadonanotubes as magnetic nanolabels for stem cell detection |
| Q37470623 | Gene and cell therapy for heart failure |
| Q36629931 | Heart valve tissue engineering: concepts, approaches, progress, and challenges |
| Q37096297 | Homing and engraftment of progenitor cells: a prerequisite for cell therapy |
| Q37313849 | Human corneal endothelial cell transplantation in a human ex vivo model |
| Q47980135 | Hypoxia enhances the therapeutic potential of superparamagnetic iron oxide-labeled adipose-derived stem cells for myocardial infarction |
| Q33760563 | Imaging approaches for the study of cell-based cardiac therapies |
| Q37222207 | Imaging in cardiac cell-based therapy: in vivo tracking of the biological fate of therapeutic cells |
| Q37103706 | Imaging of stem cells using MRI. |
| Q36656791 | Imaging stem cells implanted in infarcted myocardium |
| Q42040355 | In Situ Labeling and Magnetic Resonance Imaging of Transplanted Human Hepatic Stem Cells |
| Q37352907 | In Vivo Cellular Imaging for Translational Medical Research |
| Q42920942 | In Vivo Differentiation of Magnetically Labeled Mesenchymal Stem Cells Into Hepatocytes for Cell Therapy to Repair Damaged Liver |
| Q34478533 | In situ labeling of immune cells with iron oxide particles: an approach to detect organ rejection by cellular MRI. |
| Q37702208 | In vivo MR detection of fluorine-labeled human MSC using the bSSFP sequence. |
| Q33326522 | In vivo MR imaging of magnetically labeled mesenchymal stem cells transplanted into rat liver through hepatic arterial injection |
| Q37440349 | In vivo imaging of stem cells and Beta cells using direct cell labeling and reporter gene methods |
| Q44732593 | In vivo magnetic resonance imaging of injected mesenchymal stem cells in rat myocardial infarction; simultaneous cell tracking and left ventricular function measurement |
| Q34540793 | In vivo magnetic resonance imaging tracking of transplanted superparamagnetic iron oxide-labeled bone marrow mesenchymal stem cells in rats with myocardial infarction |
| Q37002660 | In vivo serial evaluation of superparamagnetic iron-oxide labeled stem cells by off-resonance positive contrast |
| Q36530820 | Inhibition of Viability, Proliferation, Cytokines Secretion, Surface Antigen Expression, and Adipogenic and Osteogenic Differentiation of Adipose-Derived Stem Cells by Seven-Day Exposure to 0.5 T Static Magnetic Fields |
| Q48945381 | Intra-vital fluorescence microscopy for intra-myocardial graft detection following cell transplantation |
| Q34637607 | Intramyocardial transplantation and tracking of human mesenchymal stem cells in a novel intra-uterine pre-immune fetal sheep myocardial infarction model: a proof of concept study |
| Q48427129 | Intravenous administration of 99mTc-HMPAO-labeled human mesenchymal stem cells after stroke: in vivo imaging and biodistribution |
| Q49947740 | Iron oxide labeling does not affect differentiation potential of human bone marrow mesenchymal stem cells exhibited by their differentiation into cardiac and neuronal cells. |
| Q91687333 | Labeling Stem Cells with a New Hybrid Bismuth/Carbon Nanotube Contrast Agent for X-Ray Imaging |
| Q30479903 | Labeling and Imaging of Stem Cells - Promises and Concerns |
| Q50667798 | Labeling of cynomolgus monkey bone marrow-derived mesenchymal stem cells for cell tracking by multimodality imaging. |
| Q48922938 | Labeling of skeletal myoblasts with a novel oxygen-sensing spin probe for noninvasive monitoring of in situ oxygenation and cell therapy in heart. |
| Q48841689 | Labelling of mammalian cells for visualisation by MRI. |
| Q33564003 | Long-term tracking of bone marrow progenitor cells following intracoronary injection post-myocardial infarction in swine using MRI. |
| Q35745598 | MR fluoroscopy in vascular and cardiac interventions (review) |
| Q36746521 | MR imaging in assessing cardiovascular interventions and myocardial injury |
| Q42105676 | MR imaging of transplanted stem cells in myocardial infarction |
| Q37284707 | MRI detection of single particles for cellular imaging. |
| Q28303797 | MRI evaluation of local myocardial treatments: epicardial versus endocardial (Cell-Fix catheter) injections |
| Q36108746 | MRI in guiding and assessing intramyocardial therapy. |
| Q38237380 | MRI tracking stem cells transplantation for coronary heart disease. |
| Q36350814 | MRI-guided myocardial cell therapy. |
| Q34130478 | Macrophages homing to metastatic lymph nodes can be monitored with ultrasensitive ferromagnetic iron-oxide nanocubes and a 1.5T clinical MR scanner |
| Q48654075 | Magnetic Nanoparticles Labeled Mesenchymal Stem Cells: A Pragmatic Solution toward Targeted Cancer Theranostics |
| Q26749032 | Magnetic Nanoparticles for Targeting and Imaging of Stem Cells in Myocardial Infarction |
| Q34548463 | Magnetic Resonance Microscopy (MRM) of Single Mammalian Myofibers and Myonuclei |
| Q36918024 | Magnetic and fluorescent nanoparticles for multimodality imaging. |
| Q36078215 | Magnetic bionanoparticle enhances homing of endothelial progenitor cells in mouse hindlimb ischemia |
| Q37002415 | Magnetic nanoparticles for MR imaging: agents, techniques and cardiovascular applications |
| Q30476579 | Magnetic resonance fluoroscopy allows targeted delivery of mesenchymal stem cells to infarct borders in Swine. |
| Q36861531 | Magnetic resonance imaging and fluorescence labeling of clinical-grade mesenchymal stem cells without impacting their phenotype: study in a rat model of stroke |
| Q36804563 | Magnetic resonance imaging and its role in myocardial regenerative therapy |
| Q36336339 | Magnetic resonance imaging contrast agents in the study of development |
| Q38736889 | Magnetic resonance imaging for characterizing myocardial diseases |
| Q42726387 | Magnetic resonance imaging of cells in experimental disease models |
| Q37471467 | Magnetic resonance imaging of chondrocytes labeled with superparamagnetic iron oxide nanoparticles in tissue-engineered cartilage |
| Q48932596 | Magnetic resonance imaging of haemorrhage within reperfused myocardial infarcts: possible interference with iron oxide-labelled cell tracking? |
| Q50688699 | Magnetic resonance imaging probes for labeling of chondrocyte cells. |
| Q48943581 | Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy |
| Q51201458 | Magnetic targeting of human mesenchymal stem cells with internalized superparamagnetic iron oxide nanoparticles. |
| Q28247202 | Magnetically enhanced nucleic acid delivery. Ten years of magnetofection-progress and prospects |
| Q36972669 | Mesenchymal stem cell administration at coronary artery reperfusion in the rat by two delivery routes: a quantitative assessment |
| Q36056155 | Mesenchymal stem cells for cardiac regeneration: translation to bedside reality |
| Q36110432 | Mesenchymal stem cells: future source for reparative medicine |
| Q37079267 | Molecular MR Imaging Probes |
| Q30489494 | Molecular imaging of endothelial progenitor cell engraftment using contrast-enhanced ultrasound and targeted microbubbles |
| Q35180221 | Molecular imaging, biodistribution and efficacy of mesenchymal bone marrow cell therapy in a mouse model of Chagas disease |
| Q41879334 | Molecular magnetic resonance imaging |
| Q39663325 | Multimodality Molecular Imaging of Cardiac Cell Transplantation: Part II. In Vivo Imaging of Bone Marrow Stromal Cells in Swine with PET/CT and MR Imaging |
| Q30477993 | Multimodality cardiovascular molecular imaging technology |
| Q30438207 | Multimodality cardiovascular molecular imaging, Part II |
| Q53573264 | Myocardial biopsy findings and gadolinium enhanced cardiovascular magnetic resonance in dilated cardiomyopathy. |
| Q43014093 | Myocardial gene and cell delivery |
| Q42015303 | Myocardial injection with GSK-3β-overexpressing bone marrow-derived mesenchymal stem cells attenuates cardiac dysfunction after myocardial infarction. |
| Q35168352 | Myocardial remodeling: cellular and extracellular events and targets |
| Q45883098 | Non-invasive analysis of myoblast transplants in rodent cardiac muscle |
| Q35296760 | Non-invasive longitudinal tracking of human amniotic fluid stem cells in the mouse heart |
| Q37767614 | Non-surgical stem cell delivery strategies and in vivo cell tracking to injured myocardium. |
| Q47127326 | Noninvasive Assessment of Cell Fate and Biology in Transplanted Mesenchymal Stem Cells |
| Q30481557 | Noninvasive cardiovascular imaging techniques for basic science research: application to cellular therapeutics |
| Q36136721 | Noninvasive imaging of cardiac gene expression and its future implications for molecular therapy |
| Q37181560 | Noninvasive imaging of cell-mediated therapy for treatment of cancer |
| Q48762293 | Noninvasive in vivo tracking of mesenchymal stem cells and evaluation of cell therapeutic effects in a murine model using a clinical 3.0 T MRI. |
| Q37907966 | Noninvasive stem cell tracking |
| Q39834656 | Novel approach to improve molecular imaging research: Correlation between macroscopic and molecular pathological findings in patients |
| Q37731738 | Pathophysiology of myocardial injury and remodeling: implications for molecular imaging |
| Q37133859 | Permanent coronary artery occlusion: cardiovascular MR imaging is platform for percutaneous transendocardial delivery and assessment of gene therapy in canine model |
| Q30457905 | Photoacoustic imaging of mesenchymal stem cells in living mice via silica-coated gold nanorods |
| Q36224100 | Potential application for mesenchymal stem cells in the treatment of cardiovascular diseases. |
| Q34367266 | Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases |
| Q38001396 | Principles and emerging applications of nanomagnetic materials in medicine |
| Q41127363 | Reperfusion injury components and manifestations determined by cardiovascular MR and MDCT imaging |
| Q48566449 | Second Annual Mario S. Verani, MD, Memorial Lecture: Nuclear cardiology, the next 10 years |
| Q41828756 | Serial noninvasive in vivo positron emission tomographic tracking of percutaneously intramyocardially injected autologous porcine mesenchymal stem cells modified for transgene reporter gene expression. |
| Q57345350 | Stem Cell Labeling and Tracking with Nanoparticles |
| Q35125820 | Stem Cell Therapy in Acute Myocardial Infarction: A Pot of Gold or Pandora's Box. |
| Q34786978 | Stem cell therapy: MRI guidance and monitoring |
| Q36368239 | Stem cell transplantation for the treatment of myocardial infarction |
| Q37777384 | Superparamagnetic Iron Oxide Labeling of Stem Cells for MRI Tracking and Delivery in Cardiovascular Disease |
| Q37986729 | Superparamagnetic iron oxide (SPIO) labeling efficiency and subsequent MRI tracking of native cell populations pertinent to pulmonary heart valve tissue engineering studies |
| Q41808085 | Targeted transplantation of iron oxide-labeled, adipose-derived mesenchymal stem cells in promoting meniscus regeneration following a rabbit massive meniscal defect |
| Q30441655 | Technology insight: in vivo cell tracking by use of MRI. |
| Q38069962 | The application of super paramagnetic iron oxide-labeled mesenchymal stem cells in cell-based therapy |
| Q48938444 | The role of noninvasive imaging techniques in the assessment of stem cell therapy after acute myocardial infarction |
| Q37157134 | Tracking cells implanted into cynomolgus monkeys (Macaca fascicularis) using MRI. |
| Q30443013 | Tracking of stem cells in vivo for cardiovascular applications |
| Q35691795 | Tracking stem cells for cardiovascular applications in vivo: focus on imaging techniques |
| Q39128194 | Tracking stem cells with superparamagnetic iron oxide nanoparticles: perspectives and considerations. |
| Q35576501 | Tracking the fate of stem cell implants with fluorine-19 MRI |
| Q37479807 | Tracking the migration of cardially delivered therapeutic stem cells in vivo: state of the art. |
| Q48938323 | Ultra-small gadolinium oxide nanoparticles to image brain cancer cells in vivo with MRI. |
| Q39653154 | Value of MR contrast media in image-guided body interventions |
| Q37372205 | Whole body tracking of superparamagnetic iron oxide nanoparticle-labelled cells--a rheumatoid arthritis mouse model |
| Q79449729 | [Advances in cardiovascular medicine through molecular imaging] |
Search more.